4 episodes

Is there a contradiction between profit-making and medical needs? How important are emerging markets for the future of pharmaceutical companies? And what are the ethical boundaries in the relationship between medical practitioners and pharma companies? This series of four lectures brings together leading figures in the pharmaceutical industry, health and business to look at the challenges of reconciling medical ethics and business in the 21st century against a backdrop of scientific and clinical developments and the expectations of patients.

This series was originally delivered as the 2009 Green Templeton Lectures entitled "Addicted to Big Pharma? Reconciling business, medical and ethical needs".

Pharmaceutical Industry: Past, Present and Future Oxford University

    • Education
    • 4.0 • 9 Ratings

Is there a contradiction between profit-making and medical needs? How important are emerging markets for the future of pharmaceutical companies? And what are the ethical boundaries in the relationship between medical practitioners and pharma companies? This series of four lectures brings together leading figures in the pharmaceutical industry, health and business to look at the challenges of reconciling medical ethics and business in the 21st century against a backdrop of scientific and clinical developments and the expectations of patients.

This series was originally delivered as the 2009 Green Templeton Lectures entitled "Addicted to Big Pharma? Reconciling business, medical and ethical needs".

    Is there a healthy future for Big Pharma?

    Is there a healthy future for Big Pharma?

    Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. The Pharmaceutical industry has been through a period of unprecedented growth in the last three decades, fuelled by the advances in biomedical science and an increasingly affluent Western Society. Looking forward, the picture is less rosy with reduced research and development productivity coupled with increasing pre-registration data demands from regulators and burgeoning costs. Taken together with major products losing patent protection and the need for health care costs to be kept under control, the current business model is under threat. Dr Patterson will review the background to the crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors.

    • 47 min
    A Pharma perspective on healthcare needs and innovation in drug discovery

    A Pharma perspective on healthcare needs and innovation in drug discovery

    The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. The Green Templeton Lectures 2009 explored the theme 'Addicted to Big Pharma? Reconciling business, medical and ethical needs' in a series of four lectures looking at the pharmaceutical industry past, present and future. This third lecture was delivered by Patrick Vallance (Head of Drug Discovery; GlaxoSmithKline) Philip Bloomer (Director of Campaigns; Oxfam)

    • 57 min
    Pharmaceutical Companies, Government and Society

    Pharmaceutical Companies, Government and Society

    This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment.

    • 37 min
    Pharmaceutical Industry: Origin and Evolution

    Pharmaceutical Industry: Origin and Evolution

    Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. The strong focus on British companies is not exclusive, and a large cast of characters including manufacturers, doctors, scientists and patients are considered. Several themes are explored, including the role of innovation in relation to production technology, marketing and advertising, and in particular in pharmaceutical research and drug discovery. The impact of legislation is examined with respect to animal experimentation, standardisation and drug safety. These changes will be discussed against a background of scientific advances, clinical developments and patient expectations.

    • 55 min

Customer Reviews

4.0 out of 5
9 Ratings

9 Ratings

Top Podcasts In Education

Jordan Harbinger
Dr. Jordan B. Peterson
Ashley Corbo
Natasha Graziano
Rich Roll
TED

You Might Also Like

More by Oxford University

Oxford University
Oxford University
Oxford University
Oxford University
Oxford University
Oxford University